Generic Drug Profitability: How Manufacturers Survive Price Wars
Explore the struggle for generic manufacturer profitability, from the commodity trap to the rise of complex generics and the CMO business model.
Read MoreExplore the struggle for generic manufacturer profitability, from the commodity trap to the rise of complex generics and the CMO business model.
Read MoreThe global generic drugs market is set to reach $689 billion by 2034, driven by rising chronic diseases, biosimilars, and demand in emerging economies. Learn how India, China, and regulatory shifts are reshaping affordable healthcare.
Read More